Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
Blanchard, Neil
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet. 2010 Mar 06; 375(9717):807-15.
View in:
PubMed
subject areas
Administration, Oral
Administration, Oral
Aged
Aged
Anticoagulants
Anticoagulants
Arthroplasty, Replacement, Knee
Arthroplasty, Replacement, Knee
Double-Blind Method
Double-Blind Method
Enoxaparin
Enoxaparin
Female
Female
Fibrinolytic Agents
Fibrinolytic Agents
Humans
Humans
Injections, Subcutaneous
Injections, Subcutaneous
Male
Male
Middle Aged
Middle Aged
Postoperative Complications
Postoperative Complications
Pyrazoles
Pyrazoles
Pyridones
Pyridones
Venous Thromboembolism
Venous Thromboembolism
authors with profiles
Gary E Raskob